Wikipedia

Methallatal

Methallatal
Clinical data
Trade namesMosidal
Identifiers
  • 5-ethyl-5-(2-methylprop-2-enyl)-2-sulfanylidene-1,3-diazinane-4,6-dione
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.003.723 Edit this at Wikidata
Chemical and physical data
FormulaC10H14N2O2S
Molar mass226.29 g·mol−1
3D model (JSmol)
  • CCC1(C(=O)NC(=S)NC1=O)CC(=C)C
  • InChI=1S/C10H14N2O2S/c1-4-10(5-6(2)3)7(13)11-9(15)12-8(10)14/h2,4-5H2,1,3H3,(H2,11,12,13,14,15)
  • Key:XMQICEWOKPEQRG-UHFFFAOYSA-N

Methallatal is a barbiturate derivative first synthesized in the 1940s (designation V-12).[1][2] It has sedative and hypnotic properties.

Methallatal was formerly marketed under the trade name Mosidal from 1940s to 1950s for veterinary use, specifically for preventing motion sickness in dogs.[2]

References

[edit]
  1. ^ Carson GB (1954). The barbiturates in forensic chemistry. Ohio State University. Retrieved 2026-02-11.
  2. ^ a b Elliott KA, Noble RL (September 1948). "Control of car sickness in a dog by V-12 (mosidal)". Canadian Medical Association Journal. 59 (3): 277. PMC 1591212. PMID 18877437.
Stub icon

This sedative-related article is a stub. You can help Wikipedia by adding missing information.